Distribution of dopamine receptors D1- and D2-immunoreactive neurons in the dorsal motor nucleus of vagus in rats

Autonomic Neuroscience: Basic and Clinical

Volumn 176, Issue 1-2, 2013, Pages 48-53

  Cai, Qing Qing ^a   Zheng, Li Fei ^b   Fan, Rui Fang ^b   Lian, Hui ^a   Zhou, Li ^a   Song, Hai yan ^a   Tang, Yuan Yuan ^a   Feng, Xiao Yan ^b   Guo, Zhi Kun ^a   Wang, Zhi Yong ^a   Zhu, Jin Xia ^a,b  

^a XINXIANG MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Choline acetyltransferase; Dopamine receptor; Dorsal motor nucleus of vagus; Parkinson's disease; Tyrosine hydroxylase

Indexed keywords

CHOLINE ACETYLTRANSFERASE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ARTICLE; CATECHOLAMINE NERVE CELL; CHOLINERGIC NERVE; CONFOCAL MICROSCOPY; IMMUNOFLUORESCENCE; IMMUNOREACTIVITY; MALE; MOTONEURON NUCLEUS; NEUROCHEMISTRY; NISSL STAINING; NONHUMAN; PRIORITY JOURNAL; RAT; VAGUS NERVE NUCLEUS;

ANIMALS; IMMUNOCHEMISTRY; MALE; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; VAGUS NERVE;

EID: 84877596268     PISSN: 15660702     EISSN: 18727484     Source Type: Journal    
DOI: 10.1016/j.autneu.2013.01.007     Document Type: Article

References (34)

1. Aguilar M.J., Estan L., Martinez-Mir I., Martinez-Abad M., Rubio E., Morales-Olivas F.J. Effects of dopamine in isolated rat colon strips. Can. J. Physiol. Pharmacol. 2005, 83:447-452.
2. Armstrong D.M., Manley L., Haycock J.W., Hersh L.B. Co-localization of choline acetyltransferase and tyrosine hydroxylase within neurons of the dorsal motor nucleus of the vagus. J. Chem. Neuroanat. 1990, 3:133-140.
3. Baldessarini R.J., Tarazi F.I. Brain dopamine receptors: a primer on their current status, basic and clinical. Harv. Rev. Psychiatry 1996, 3:301-325.
4. Berk M.L. Projections of the lateral hypothalamus and bed nucleus of the stria terminalis to the dorsal vagal complex in the pigeon. J. Comp. Neurol. 1987, 260:140-156.
5. Bouthenet M.L., Martres M.P., Sales N., Schwartz J.C. A detailed mapping of dopamine D-2 receptors in rat central nervous system by autoradiography with [125I]iodosulpride. Neuroscience 1987, 20:117-155.
6. Braak H., Rub U., Gai W.P., Del Tredici K. Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J. Neural. Transm. 2003, 110:517-536.
7. Cersosimo M.G., Benarroch E.E. Autonomic involvement in Parkinson's disease: pathology, pathophysiology, clinical features and possible peripheral biomarkers. J. Neurol. Sci. 2012, 313:57-63.
8. Chaillou E., Tillet Y., Malbert C.H. Organisation of the catecholaminergic system in the vagal motor nuclei of pigs: a retrograde fluorogold tract tracing study combined with immunohistochemistry of catecholaminergic synthesizing enzymes. J. Chem. Neuroanat. 2009, 38:257-265.
9. Chang H.Y., Mashimo H., Goyal R.K. Musings on the wanderer: what's new in our understanding of vago-vagal reflex? IV. Current concepts of vagal efferent projections to the gut. Am. J. Physiol. Gastrointest. Liver Physiol. 2003, 284:G357-G366.
10. Hyde T.M., Knable M.B., Murray A.M. Distribution of dopamine D1-D4 receptor subtypes in human dorsal vagal complex. Synapse 1996, 24:224-232.
11. Kalia M., Fuxe K., Goldstein M., Harfstrand A., Agnati L.F., Coyle J.T. Evidence for the existence of putative dopamine-, adrenaline- and noradrenaline-containing vagal motor neurons in the brainstem of the rat. Neurosci. Lett. 1984, 50:57-62.
12. Kalia M., Fuxe K., Goldstein M. Rat medulla oblongata. II. Dopaminergic, noradrenergic (A1 and A2) and adrenergic neurons, nerve fibers, and presumptive terminal processes. J. Comp. Neurol. 1985, 233:308-332.
13. Kawamura Y., Fukaya M., Maejima T., Yoshida T., Miura E., Watanabe M., Ohno-Shosaku T., Kano M. The CB1 cannabinoid receptor is the major cannabinoid receptor at excitatory presynaptic sites in the hippocampus and cerebellum. J. Neurosci. 2006, 26:2991-3001.
14. Koda L.Y., Bloom F.E. Distribution of catecholamine-containing cell bodies and blood vessels in the rat nucleus tractus solitarius. Brain Res. 1983, 289:71-78.
15. Li Z.S., Pham T.D., Tamir H., Chen J.J., Gershon M.D. Enteric dopaminergic neurons: definition, developmental lineage, and effects of extrinsic denervation. J. Neurosci. 2004, 24:1330-1339.
16. Li Z.S., Schmauss C., Cuenca A., Ratcliffe E., Gershon M.D. Physiological modulation of intestinal motility by enteric dopaminergic neurons and the D2 receptor: analysis of dopamine receptor expression, location, development, and function in wild-type and knock-out mice. J. Neurosci. 2006, 26:2798-2807.
17. Manor Y., Balas M., Giladi N., Mootanah R., Cohen J.T. Anxiety, depression and swallowing disorders in patients with Parkinson's disease. Parkinsonism Relat. Disord. 2009, 15:453-456.
18. Natale G., Pasquali L., Ruggieri S., Paparelli A., Fornai F. Parkinson's disease and the gut: a well known clinical association in need of an effective cure and explanation. Neurogastroenterol. Motil. 2008, 20:741-749.
19. Okuma Y., Osumi Y. Central cholinergic descending pathway to the dorsal motor nucleus of the vagus in regulation of gastric functions. Jpn. J. Pharmacol. 1986, 41:373-379.
20. Reiner P.B., Vincent S.R. The distribution of tyrosine hydroxylase, dopamine-beta-hydroxylase, and phenylethanolamine-N-methyltransferase immunoreactive neurons in the feline medulla oblongata. J. Comp. Neurol. 1986, 248:518-531.
21. Swanson L.W., Sawchenko P.E., Berod A., Hartman B.K., Helle K.B., Vanorden D.E. An immunohistochemical study of the organization of catecholaminergic cells and terminal fields in the paraventricular and supraoptic nuclei of the hypothalamus. J. Comp. Neurol. 1981, 196:271-285.
22. Tian Y.M., Chen X., Luo D.Z., Zhang X.H., Xue H., Zheng L.F., Yang N., Wang X.M., Zhu J.X. Alteration of dopaminergic markers in gastrointestinal tract of different rodent models of Parkinson's disease. Neuroscience 2008, 153:634-644.
23. Travagli R.A., Hermann G.E., Browning K.N., Rogers R.C. Brainstem circuits regulating gastric function. Annu. Rev. Physiol. 2006, 68:279-305.
24. Tsukamoto K., Hayakawa T., Maeda S., Tanaka K., Seki M., Yamamura T. Projections to the alimentary canal from the dopaminergic neurons in the dorsal motor nucleus of the vagus of the rat. Auton. Neurosci. Basic Clin. 2005, 123:12-18.
25. Vuckovic M.G., Li Q., Fisher B., Nacca A., Leahy R.M., Walsh J.P., Mukherjee J., Williams C., Jakowec M.W., Petzinger G.M. Exercise elevates dopamine D2 receptor in a mouse model of Parkinson's disease: in vivo imaging with [(1)(8)F]fallypride. Mov. Disord. 2010, 25:2777-2784.
26. Wang Q., Ji T., Zheng L.F., Feng X.Y., Wang Z.Y., Lian H., Song J., Li X.F., Zhang Y., Zhu J.X. Cellular localization of dopamine receptors in the gastric mucosa of rats. Biochem. Biophys. Res. Commun. 2012, 417:197-203.
27. Willett C.J., Rutherford J.G., Gwyn D.G., Leslie R.A. Projections between the hypothalamus and the dorsal vagal complex in the cat: an HRP and autoradiographic study. Brain Res. Bull. 1987, 18:63-71.
28. Yokoyama C., Okamura H., Nakajima T., Taguchi J., Ibata Y. Autoradiographic distribution of [3H]YM-09151-2, a high-affinity and selective antagonist ligand for the dopamine D2 receptor group, in the rat brain and spinal cord. J. Comp. Neurol. 1994, 344:121-136.
29. Zhang X.H., Zhang X.F., Zhang J.Q., Tian Y.M., Xue H., Yang N., Zhu J.X. Beta-adrenoceptors, but not dopamine receptors, mediate dopamine-induced ion transport in late distal colon of rats. Cell Tissue Res. 2008, 334:25-35.
30. Zhang X.H., Ji T., Guo H., Liu S.M., Li Y., Zheng L.F., Zhang Y., Zhang X.F., Duan D.P. Expression and activation of beta-adrenoceptors in the colorectal mucosa of rat and human. Neurogastroenterol. Motil. 2010, 22:e325-e334.
31. Zhang X., Guo H., Xu J., Li Y., Li L., Zhang X., Li X., Fan R., Zhang Y., Duan Z., Zhu J. Dopamine receptor D1 mediates the inhibition of dopamine on the distal colonic motility. Transl. Res. 2012, 159:407-414.
32. Zheng Z., Travagli R.A. Dopamine effects on identified rat vagal motoneurons. Am. J. Physiol. Gastrointest. Liver Physiol. 2007, 292:G1002-G1008.
33. Zheng L.F., Wang Z.Y., Li X.F., Song J., Hong F., Lian H., Wang Q., Feng X.Y., Tang Y.Y., Zhang Y., Zhu J.X. Reduced expression of choline acetyltransferase in vagal motoneurons and gastric motor dysfunction in a 6-OHDA rat model of Parkinson's disease. Brain Res. 2011, 1420:59-67.
34. Ziemssen T., Reichmann H. Non-motor dysfunction in Parkinson's disease. Parkinsonism Relat. Disord. 2007, 13:323-332.